The opiod crisis has recently been taking up alot of coverage in the media in the US, Indeed, deaths from overdoses due to opiods in the US alone are greater than the deaths from auto accidents each year. Many organizations have been working diligently to develop abuse deterrent opioid medications to combat addiction.

Purdue University have long been working on this and we wanted to share a presentation deck titled “Development and Regulation of Abuse Deterrent Opioid Medications” from Steve Byrn from Purdue University. This talk was given during one of our previous Global Drug Bioavailability Enhancement Summits. This presentation gives us a brief history of abuse deterrent opiod medications, regulatory and therapeuic considerations, findings and touches upon other abuse deterrent approaches

Scroll through the presentation below……

2021 Global Drug Bioavailability Enhancement Summit

(Nov 3 - 4, 2021)

 

Interested to improve the performance of your drug products? Learn 2 years of new drug product development approaches at the 2021 Global Drug Bioavailability Enhancement Virtual Summit this November.

Join 100's of leading drug delivery, formulation and development experts and hear 25+ expert sessions. Gain over 2 years worth of new drug product development strategies, formulation approaches, delivery technologies and regulatory updates while decreasing drug product time-to-market in just 2 short days (all available on-demand)!

Save over 10% on attendance registration before October 30th, 2021 (Only $449). Likewise, have a platform technology you would like to explore showcasing to the wider audience this November? Reach out below to find out remaining opportunities.

2021 On-Demand Summits Available for Purchase

(Limited time - Only $299)

Pin It on Pinterest

Share This

Share this with a friend or colleague!